[MO12] Mini-Oral Session 12　Hematologic Malignancies 2（Lymphoid）
【E】

[MO12-5] Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine

^○Yutaka Shimazu¹, Shohei Mizuno², Shin-Ichi Fuchida³, Kazuhito Suziki⁴, Nobuhiro Tsukada⁵, Akira Hanagaishi⁶, Mitsuhiro Itagaki⁷, Keisuke Kataoka⁸, Shinichi Kako⁹, Emiko Sakaida¹⁰, Satoshi Yoshioka¹¹, Shinsuke Iida¹², Noriko Doki¹³, Tatsuo Oyake¹⁴, Tatsuo Ichinohe¹⁵, Yoshinobu Kanda¹⁶, Yoshiko Astuta^17,18, Hiroyuki Takamatsu¹⁹ (1.Department of Hematology, Kyoto University Hospital, 2.Department of Internal Medicine, Aichi Medical University School of Medicine, 3.Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center, 4.Department of Clinical Oncology / Hematology, the Jikei University Kashiwa Hospital, 5.日本赤十字社医療センター 血液内科, 6.Department of Hematology, National Center for Global Health and Medicine, 7.Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, 8.Division of Hematology, Department of Medicine, Keio University School of Medicine, 9.Division of Hematology, Jichi Medical University Saitama Medical Center, 10.Department of Hematology, Chiba University Hospital, 11.Department of Hematology, Kobe City Medical Center General Hospital, 12.Division of Hematology & Oncology, Nagoya City University Hospital, 13.Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 14.Division of Hematology and Oncology, Iwate Medical University, 15.Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 16.Division of Hematology, Department of Medicine, Jichi Medical University, 17.Japanese Data Center for Hematopoietic Cell Transplantation, 18.Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, 19.Department of Hematology, Kanazawa University)